Many Flavored E-Cigarettes Contain Benzaldehyde

This article originally appeared here.
Share this content:
Many Flavored E-Cigarettes Contain Benzaldehyde
Many Flavored E-Cigarettes Contain Benzaldehyde

FRIDAY, Jan. 29, 2016 (HealthDay News) -- Most flavored electronic cigarettes contain benzaldehyde, which has been shown to cause irritation of the respiratory airways in animal and occupational exposure studies, according to a research letter published online Jan. 28 in Thorax.

Leon Kosmider, from the Institute of Occupational Medicine and Environmental Health in Sosnowiec, Poland, and colleagues measured benzaldehyde in aerosol generated in a laboratory setting from flavored e-cigarettes.

The researchers detected benzaldehyde in 108 out of 145 products, with the highest levels detected in cherry-flavored products. The benzaldehyde dose inhaled with 30 puffs was frequently higher from flavored versus conventional cigarettes. The estimated median daily inhaled dose of benzaldehyde from cherry-flavored e-cigarettes was 70.3 µg, which was more than 1,000 times lower than doses inhaled in the workplace.

"While e-cigarettes seem to be a promising harm reduction tool for smokers, findings indicate that using these products could result in repeated inhalation of benzaldehyde, with long-term users risking regular exposure to the substance," the authors write. "Given the uncertainty surrounding adverse health effects stemming from long-term inhalation of flavoring ingredients such as benzaldehyde, clinicians need to be aware of this emerging risk and ask their patients about use of flavored e-cigarettes."

Two authors disclosed financial ties to companies that manufacture electronic cigarettes.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA OKs Doptelet for Liver Dz Patients Undergoing Procedures

FDA OKs Doptelet for Liver Dz Patients Undergoing ...

Doptelet reduces the need for platelet transfusion or any rescue therapy on day of procedure

Slower Decline in Lung Function With Anthocyanin Intake

Slower Decline in Lung Function With Anthocyanin Intake

Slower annual rates of decline in FEV1 and FVC for those in highest quartile of anthocyanin intake

Bioengineering Feasible for Airway Reconstruction

Bioengineering Feasible for Airway Reconstruction

Bioengineered tracheal and bronchial reconstruction reported using stented aortic matrices

is free, fast, and customized just for you!

Already a member?

Sign In Now »